logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

On October 27, SIM TECH (02000) spent HK$516,960 to repurchase 1,454,000 shares.

date
16:43 27/10/2025
avatar
GMT Eight
Morning Tech (02000) announced on October 27, 2025, to repurchase a total of HK$51.696 million...
SIM TECH (02000) announced that it will spend 516,960 Hong Kong dollars on October 27, 2025 to repurchase 1,454,000 shares.
Related Articles
HK Stock
CANSINOBIO (06185): Zuo Min and Ji Xuefeng nominated as independent non-executive director candidates.
Preview of US Stock Market | Three major stock index futures rose together, and progress was made in the China-US trade negotiations.
HK Stock
CHINARES PHARMA(03320): China Resources Boya Bio-pharmaceutical Group's net profit for the first three quarters was 343 million yuan, a decrease of 16.8% year-on-year.
CANSINOBIO (06185): Zuo Min and Ji Xuefeng nominated as independent non-executive director candidates.
HK Stock
Preview of US Stock Market | Three major stock index futures rose together, and progress was made in the China-US trade negotiations.
CHINARES PHARMA(03320): China Resources Boya Bio-pharmaceutical Group's net profit for the first three quarters was 343 million yuan, a decrease of 16.8% year-on-year.
HK Stock
RECOMMEND
Why European Automakers Are Opposing Dutch Sanctions
Why European Automakers Are Opposing Dutch Sanctions
icon
20/10/2025
Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
icon
20/10/2025
Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
icon
20/10/2025
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.